The Anecare ANEclear Economic Benefits

Rapid removal of residual inhaled anesthetics following surgery reduces side effects and complications, including Post Operative Nausea and Vomiting (PONV) and respiratory complications such as Obstructive Sleep Apnea (OSA). These complications lead to patient discomfort, prolonged postoperative stay, unanticipated admissions and increased costs.

The ANEclear is an inexpensive, easy-to-use disposable device that actively removes inhaled anesthetics at the end of surgery to reverse the anesthetics’ effects and does so without the use of any drugs. It reduces risk and improves patient care for challenging patients, including:

  • Elderly patients
  • Overweight patients
  • Patients at risk for OSA
  • Patients at risk for PONV

The ANEclear improves surgical outcomes for better safety and quality of patient care, which:

  • Improves the patient experience
  • Increases OR throughput
  • Improves surgeon satisfaction
  • Helps drive surgical volume growth

In addition to the clinical and patient satisfaction benefits, the ANEclear has a positive impact on your bottom line.

In spite of receiving anti-nausea drugs during surgery, 26% of patients still require additional treatment in the Post-Anesthesia Care Unit (PACU), and 40% of patients require additional treatment for PONV following discharge.1, 2 PONV is also associated with poor surgical outcomes, prolonged healing and wound disruption. Commonly used anti-nausea drugs have a sedating effect, which may prolong time to discharge and increase the risk of obstruction for OSA patients.

Recent studies show the ANEclear reduces the need for rescue anti-nausea drugs in the PACU by 85%.3, 4 This means the ANEclear offers improved patient outcomes and satisfaction as well as a positive economic impact for facilities.

Economic Impact – for each incident of nausea/vomiting that is avoided:

  • Avoid resource utilization costs:  Patients who vomit spend an average of 43 minutes longer in the PACU at a cost of $85 for nausea and $138 for vomiting.5, 6
  • Save the cost of rescue treatment:  $283 (minimum) to treat patients who experience PONV.7
  • For surgical centers:  PONV delays may result in an ambulance transfer to a hospital costing $300 - $900 and result in an admission costing $1,200 to more than $2,400 per day.
  • Example of economic impact:
    • Assuming 10,000 general anesthetics per year
    • Using the ANEclear on patients at risk for PONV (approx 25%) = 2,500 patients
    • Using the ANEclear at $39 on 2,500 patients = $97,500
    • Typically 26% of patients experience PONV at $85 (minimum cost) = $221,000
    • 2,210 patients avoid rescue treatment at $85 each = $187,850 savings

(10,000 patients x 26% rescue treatment x 85% saved by ANEclear x $85 minimum cost)

Studies show that 22% - 39% of all surgical patients are at high risk for OSA. Worse, 80% of those patients are undiagnosed.8, 9 During recovery, residual inhaled anesthetics increase the number and duration of sleep apnea episodes but inhibit arousals which would normally occur during such episodes. Accelerating the elimination of inhaled anesthetics with the ANEclear allows patients to be awake, alert and in control of their airway more rapidly. This is particularly critical to ensure safety for OSA patients.

Economic Impact – for each patient with OSA avoiding respiratory complications

  • Avoid additional PACU costs:  Guidelines from the American Society of Anesthesiologists (ASA) for perioperative care of OSA patients suggest patients should stay in recovery for an extended period after the last episode (de-saturation, re-intubation, hypoxia, etc.). Eliminating these complications reduces PACU time at a cost of $4 - $8 per minute.
  • Avoid costly ICU admissions:  Residual inhaled anesthetics in OSA patients may contribute to the inability of physicians to extubate these patients following surgery resulting in an ICU stay (average $2,464 per day for respiratory ICU).
  • Save by reducing complications:  OSA patients are 2 - 3 times more likely to require re-intubation due to airway obstruction, which frequently results in an ICU stay or unplanned hospital admission.8

Patients who have the anesthetic agent actively removed from their system are more likely to be alert and more in control of their airway upon entering the PACU. These patients are more apt to meet discharge criteria sooner.

Economic Impact

  • Reduce PACU recovery time:  Save $92 through a 35% reduction in PACU recovery time (average 23 minutes) at a cost of $4 per minute (range $4 - $8 per minute).10 Higher PACU throughput provides a lower probability of PACU admission delays as well as a lower likelihood of PACU discharge delays.
  • Avoid overtime costs:  A shorter PACU stay frees PACU bed space and helps to avoid overtime costs.

The ANEclear improves early patient recovery from inhaled anesthetics. Active elimination of the inhaled anesthetic agent from the patient provides a more rapid emergence when using any of the three primary inhaled anesthetics, whether or not the anesthetic is tapered off at the end of surgery. Reduced emergence times and increased emergence predictability provides an environment for better OR scheduling and utilization.

Economic Impact

  • A 60% reduction in anesthesia emergence time:  The ANEclear reduces anesthesia emergence time by up to 60% saving 5 - 11 minutes of OR time per patient at $18 per minute (range $18 - $40 per minute), which generates potential savings of $90 - $198.11, 12 Reducing emergence time also leads to more predictable scheduling and more productive use of the OR and anesthesia personnel.
  • A 31% - 56% reduction in the variability of emergence time:  Reducing variability improves OR scheduling.11, 12
  • A higher profit contribution per surgical case (“contribution margin”):  Considering an average contribution margin of $1,500 per hour, the ANEclear can reduce OR time by 8.3% - 18.3% for a one hour case, potentially improving the contribution margin by $97 - $297. The total contribution margin can also be increased if additional surgeries can be performed, or overtime costs can be reduced.
  • More rapid pre-op assessment:  Shorter extubation times allow the clinician to move more rapidly to the pre-op assessment for the next case.
  • Improved surgery start times:  Less likelihood of delayed surgery start time due to delayed emergence of prior cases.

The ANEclear improves surgery outcomes and improves patient and surgeon satisfaction when used for patients at risk of PONV or OSA.

  • Reduces patients’ fear of being sick after surgery.
  • Reduces patient time and staffing costs (overtime) in the OR and PACU.
  • Patients are more alert and awake on arrival in the PACU and are better able to participate in their own pain assessment and management.
  • Patients who feel well at discharge heal better at home.
  • Improves OR throughput.
  • Satisfies surgeons with happier patients and better time management.
  • Increases surgeon satisfaction which supports OR caseload and market share growth.
  • May allow additional surgeries in busy OR’s.

[1.] Apfel CC, et al., N Engl J Med. 2004;350:2441-2451; [2.] Carroll NV et al., Anesth Analg.1995;80:903-909; [3.] McKay RE, et al., Anesth Analg. 2009;108; S-299; [4.] Sakata D et al., Anesth Analg. 2009;108; S-151; [5.] Darkow T, et al., Pharmcotherapy 2001; 21(5): 540-548; [6.] Habib AS, et al., Curr Med Res Opin. 2006; 22(6):1093-1099; [7.] Hill RP, et al., Anesthesiology. 2000; 92-4:958-967; [8.] Finkel K, et al., ASA Abstract A1727, Oct. 22, 2008; [9.] Young T, et al., Am J Resp Crit Care Med. 2002;165:1217-1239; [10.] Katznelson R, et al., Can J Anesth 2006;53:26357; [11.] Sakata DJ, et al, Anesth Analg. 2007;105(1):79-82; [12.] Sakata DJ, et al, Anesth Analg. 2007;104(3):587-91


Learn More
ANECARE, LLC. 3333 W. PARKWAY BLVD., SALT LAKE CITY, UT 84119    PH. 801.977.8877  FAX 801.977.0363    COPYRIGHT 2011 - 2012, ANECARE LLC, ALL RIGHTS RESERVED